Mark Tidswell to Treatment Outcome
This is a "connection" page, showing publications Mark Tidswell has written about Treatment Outcome.
Connection Strength
0.189
-
Tidswell M, Tillis W, Larosa SP, Lynn M, Wittek AE, Kao R, Wheeler J, Gogate J, Opal SM. Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis. Crit Care Med. 2010 Jan; 38(1):72-83.
Score: 0.036
-
Leaf DE, Monson AE, Dias JA, Marcos LA, Wu U, Rossi M, Ng JH, Patell R, Hundert J, El Khoury MY, Higgs J, Smith RP, Ramsaroop V, Green A, Abdul Azim A, Weisenberg S, Kirkman LA, Ingram D, Hsu CM, Dieckhaus K, Hyson P, Burger Z, Chengsupanimit T, Stalmack T, Aber R, Golden M, Koshy M, Wright K, Cortezzo G, McLeod G, Wenzel-Rideout R, Baigorri JJ, Bagchi A, Jaser A, Socorro Matos G, Sanchez-Almanzar D, Hoge ST, Shenoy T, Krishnamurthy S, Kaunfer SA, Blau JA, Woolley A, Zamor R, Maczaj B, Kenison D, Totten A, Bateman V, Mohsin S, Lee ES, Garner J, Rath P, Wu Q, Guermazi D, London A, Arvanitis P, Yune PS, Abdullah M, Kim A, Roy J, George R, Kashfi S, Hong S, Upadrista P, Hirsch JS, Bulteel A, Sharma R, Guo T, Garcia D, Shaefi S, Yeb J, Williams G, Verma E, Gouda N, Rosenthal HR, Chan A, Zainah H, Heithaus S, Saldivar MA, Wood E, DiPalazzo J, Elias S, McAuliffe M, Abbas R, Orenstein A, Tidswell MA, Galiano P, Spencer S, Srinivasan S, Xu J, Alla S, Alidoost L, Jacobson E, Menghani SV, Kannabran P, Ogunribido DB, Ssentongo P, Powell D, Meyer L, Prabhune K, Griffiths B, Gonzalez Aponte D, Dixon G, Vannier E, Roberts SC, Farmakiotis D, Krause PJ. Red Blood Cell Exchange Transfusion for Severe Babesiosis. JAMA Intern Med. 2026 May 01; 186(5):597-607.
Score: 0.028
-
Neyra JA, Legrand M, Tidswell MA, Al-Khafaji A, Galphin C, Rains R, Davison D, Tolwani A, Chen JT, Bender WS, Busse LW, Meena NK, DellaVolpe J, Williams GW, Kashani KB, Gunnerson KJ, McMahon BA, Eaton J, Khan S, Kohli-Seth R, Jagpal S, Klein D, Kamaluddin E, Foster DM, Walker PM, Tomlinson G, Kellum JA. Polymyxin B haemoadsorption in endotoxic septic shock (Tigris): a multicentre, open-label, Bayesian, randomised, controlled, phase 3 trial. Lancet Respir Med. 2026 May; 14(5):443-452.
Score: 0.028
-
Collins SP, Shotwell MS, Strich JR, Gibbs KW, de Wit M, Files DC, Harkins M, Hudock K, Merck LH, Moskowitz A, Apodaca KD, Barksdale A, Safdar B, Javaheri A, Sturek JM, Schrager H, Iovine NM, Tiffany B, Douglas I, Levitt J, Ginde AA, Hager DN, Shapiro N, Duggal A, Khan A, Lanspa M, Chen P, Gentile N, Harris E, Gong M, Sellers S, Goodwin AJ, Tidswell MA, Filbin M, Desai N, Guti?rrez F, Estrada V, Burgos J, Boyles T, Pa?o-Pardo JR, Hussen N, Rosenberg Y, Troendle J, Bernard GR, Bistran-Hall AJ, Walsh K, Casey JD, DeClercq J, Joly MM, Pulley J, Rice TW, Schildcrout JS, Wang L, Semler MW, Self WH. Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia: A Randomized Clinical Trial. JAMA Netw Open. 2024 12 02; 7(12):e2448215.
Score: 0.025
-
Munroe ES, Prevalska I, Hyer M, Meurer WJ, Mosier JM, Tidswell MA, Prescott HC, Wei L, Wang H, Fung CM. High-Flow Nasal Cannula Versus Noninvasive Ventilation as Initial Treatment in Acute Hypoxia: A Propensity Score-Matched Study. Crit Care Explor. 2024 May; 6(5):e1092.
Score: 0.025
-
Patel J, Bass D, Beishuizen A, Bocca Ruiz X, Boughanmi H, Cahn A, Colombo H, Criner GJ, Davy K, de-Miguel-D?ez J, Doreski PA, Fernandes S, Fran?ois B, Gupta A, Hanrott K, Hatlen T, Inman D, Isaacs JD, Jarvis E, Kostina N, Kropotina T, Lacherade JC, Lakshminarayanan D, Martinez-Ayala P, McEvoy C, Meziani F, Monchi M, Mukherjee S, Mu?oz-Berm?dez R, Neisen J, O'Shea C, Plantefeve G, Schifano L, Schwab LE, Shahid Z, Shirano M, Smith JE, Sprinz E, Summers C, Terzi N, Tidswell MA, Trefilova Y, Williamson R, Wyncoll D, Layton M. A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR). Eur Respir J. 2023 02; 61(2).
Score: 0.022
-
Lanspa MJ, Gong MN, Schoenfeld DA, Lee KT, Grissom CK, Hou PC, Serpa-Neto A, Brown SM, Iwashyna TJ, Yealy DM, Hough CL, Brower RG, Calfee CS, Hyzy RC, Matthay MA, Miller RR, Steingrub JS, Thompson BT, Miller CD, Clemmer TP, Hendey GW, Huang DT, Mathews KS, Qadir N, Tidswell M. Prospective Assessment of the Feasibility of a Trial of Low-Tidal Volume Ventilation for Patients with Acute Respiratory Failure. Ann Am Thorac Soc. 2019 03; 16(3):356-362.
Score: 0.017
-
Higgins TL, Steingrub JS, Tereso GJ, Tidswell MA, McGee WT. Drotrecogin alfa (activated) in sepsis: initial experience with patient selection, cost, and clinical outcomes. J Intensive Care Med. 2005 Nov-Dec; 20(6):339-45.
Score: 0.007